Bon Natural Life Limited (BON) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Bon Natural Life Limited, updated every trading day.
Health Care · Medicinal Chemicals and Botanical Products
Price
$1.13
−1.74% today
Market cap
$9M
Overall quality
30/100
Kronos AI 30-day
+1.7%
5 of 8 simulated paths end higher
Bon Natural Life Limited (BON) is a Health Care company in Medicinal Chemicals and Botanical Products, worth $9M. It trades at $1.13, down 1.74% today. Its overall quality score is 30 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +1.7% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.17 (+1.7%) |
| Likely range | −0.8% … +2.5% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
| Profitability | 17 |
| Solvency | 27 |
| Growth | 46 |
| Overall | 30 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medicinal Chemicals and Botanical Products
For information only, not investment advice. Prices updated: 2026-10-29.